Exploring binding potential of two new indole alkaloids from Nauclea officinalis against third and fourth generation EGFR: druglikeness, in silico ADMET, docking, DFT, molecular dynamics simulation, and MMGBSA study

References

• Dey P, Kundu A, Kumar A, Gupta M, Lee BM, Bhakta T, Dash S, Kim HS. 202. Chapter 15 - Analysis of alkaloids (indole alkaloids, isoquinoline alkaloids, tropane alkaloids), Editor(s): Ana Sanches Silva, Seyed Fazel Nabavi, Mina Saeedi, Seyed Mohammad Nabavi, In Recent advances in natural products analysis. pp. 505–567. Elsevier. https://doi.org/10.1016/B978-0-12-816455-6.00015-9.
   Google Scholar
• Dey S, Rathod S, Gumphalwad K, Yadav N, Choudhari P, Rajakumara E, Dhavale R, Mahuli D. 2023. Exploring α, β-unsaturated carbonyl compounds against bacterial efflux pumps via computational approach. J Biomol Struct Dyn. 1–14. doi:10.1080/07391102.2023.2246568.
   Web of Science ®Google Scholar
• Elkaeed EB, Yousef RG, Elkady H, Alsfouk AA, Husein DZ, Ibrahim IM, Metwaly AM, Eissa IH. 2022. New anticancer theobromine derivative targeting EGFRWT and EGFRT790M: design, semi-synthesis, in silico, and in vitro anticancer studies. Molecules. 27(18):5859. doi:10.3390/molecules27185859.
   PubMed Web of Science ®Google Scholar
• Elkaeed EB, Yousef RG, Elkady H, Gobaara IMM, Alsfouk AA, Husein DZ, Ibrahim IM, Metwaly AM, Eissa IH. 2022. The assessment of anticancer and VEGFR-2 inhibitory activities of a new 1H-Indole derivative: in silico and in vitro approaches. Processes. 10(7):1391. doi:10.3390/pr10071391.
   Web of Science ®Google Scholar
• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127(12):2893–2917. doi:10.1002/ijc.25516.
   PubMed Web of Science ®Google Scholar
• Halder S, Basu S, Lall SP, Ganti AK, Batra SK, Seshacharyulu P. 2023. Targeting the EGFR signaling pathway in cancer therapy: what’s new in 2023? Expert Opin Ther Targets. 27(4-5):305–324. doi:10.1080/14728222.2023.2218613.
   PubMed Web of Science ®Google Scholar
• Ke X, Shen L. 2017. Molecular targeted therapy of cancer: the progress and future prospect. Front Lab Med. 1(2):69–75. doi:10.1016/j.flm.2017.06.001.
   Google Scholar
• Kocarnik JM, Compton K, Dean FE, Fu W, Gaw BL, Harvey JD, Henrikson HJ, Lu D, Pennini A, Xu R, et al. 2022. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019 a systematic analysis for the global burden of disease study 2019. JAMA Oncol. 8(3):420–444. doi:10.1001/jamaoncol.2021.6987.
   PubMed Web of Science ®Google Scholar
• Kuete V, Seukep AJ. 2023. Chapter Eight – Phytochemistry and antibacterial potential of the genus Nauclea. In: Kuete V, editor. Adv Bot Res. Vol. 107. [place unknown]: Academic Press; p. 239–273. doi:10.1016/bs.abr.2022.08.018.
   Google Scholar
• Li F, Wu H, Du X, Sun Y, Rausseo BN, Talukder A, Katailiha A, Elzohary L, Wang Y, Wang Z, et al. 2023. Epidermal growth factor receptor-targeted neoantigen peptide vaccination for the treatment of non-small cell lung cancer and glioblastoma. Vaccines (Basel). 11(9):1460. doi:10.3390/vaccines11091460.
   PubMed Web of Science ®Google Scholar
• Liu B, Geng Q, Cao Z, Li L, Lu P, Lin L, Yan L, Lu C. 2022. Nauclea officinalis: a Chinese medicinal herb with phytochemical, biological, and pharmacological effects. Chinese Med (United Kingdom). 17(1):1–25.
   PubMed Web of Science ®Google Scholar
• Martínez A. 2009. Donator acceptor map of psittacofulvins and anthocyanins: are they good antioxidant substances? J Phys Chem B. 113(14):4915–4921. doi:10.1021/jp8102436.
   PubMed Web of Science ®Google Scholar
• Martínez A, Rodríguez-Gironés MA, Barbosa A, Costas M. 2008. Donator acceptor map for carotenoids, melatonin and vitamins. J Phys Chem A. 112(38):9037–9042. doi:10.1021/jp803218e.
   PubMed Web of Science ®Google Scholar
• Mulliken RS. 1932. Electronic structures of polyatomic molecules and valence. II. General considerations. Phys Rev. 41(1):49–71. doi:10.1103/PhysRev.41.49.
   Google Scholar
• Mumit MA, Pal TK, Alam MA, Islam M, Paul S, Sheikh MC. 2020. DFT studies on vibrational and electronic spectra, HOMO–LUMO, MEP, HOMA, NBO and molecular docking analysis of benzyl-3-N-(2,4,5-trimethoxyphenylmethylene)hydrazinecarbodithioate. J Mol Struct. 1220:128715. doi:10.1016/j.molstruc.2020.128715.
   PubMed Web of Science ®Google Scholar
• Omar F, Tareq AM, Alqahtani AM, Dhama K, Sayeed MA, Emran TB, Simal-Gandara J. 2021. Plant-based indole alkaloids: a comprehensive overview from a pharmacological perspective. Molecules. 26(8):2297. doi:10.3390/molecules26082297.
   PubMed Web of Science ®Google Scholar
• Parr RG, Pearson RG. 1983. Absolute hardness: companion parameter to absolute electronegativity. J Am Chem Soc. 105(26):7512–7516. doi:10.1021/ja00364a005.
   Web of Science ®Google Scholar
• Paz-Ares L, Soulières D, Melezínek I, Moecks J, Keil L, Mok T, Rosell R, Klughammer B. 2010. Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis. J Cell Mol Med. 14(1-2):51–69. doi:10.1111/j.1582-4934.2009.00991.x.
   PubMed Web of Science ®Google Scholar
• Queiroz AN, Gomes BAQ, Moraes WM, Borges RS. 2009. A theoretical antioxidant pharmacophore for resveratrol. Eur J Med Chem. 44(4):1644–1649. doi:10.1016/j.ejmech.2008.09.023.
   PubMed Web of Science ®Google Scholar
• Rathod S, Chavan P, Mahuli D, Rochlani S, Shinde S, Pawar S, Choudhari P, Dhavale R, Mudalkar P, Tamboli F. 2023. Exploring biogenic chalcones as DprE1 inhibitors for antitubercular activity via in silico approach. J Mol Model. 29(4):113. doi:10.1007/s00894-023-05521-8.
   PubMed Web of Science ®Google Scholar
• Rathod S, Dey S, Pawar S, Dhavale R, Choudhari P, Rajakumara E, Mahuli D, Bhagwat D, Tamboli Y, Sankpal P, et al. 2023. Identification of potential biogenic chalcones against antibiotic resistant efflux pump (AcrB) via computational study. J Biomol Struct Dyn. 1–19. doi:10.1080/07391102.2023.2225099.
   Web of Science ®Google Scholar
• Rathod S, Shinde K, Porlekar J, Choudhari P, Dhavale R, Mahuli D, Tamboli Y, Bhatia M, Haval KP, Al-Sehemi AG, et al. 2022. Computational exploration of anti-cancer potential of flavonoids against cyclin-dependent kinase 8: an in silico molecular docking and dynamic approach. ACS Omega. 8(1):391–409. doi:10.1021/acsomega.2c04837.
   PubMed Web of Science ®Google Scholar
• Rochlani S, Bhatia M, Rathod S, Choudhari P, Dhavale R. 2023. Exploration of limonoids for their broad spectrum antiviral potential via DFT, molecular docking and molecular dynamics simulation approach. Nat Prod Res. :1–6. doi:10.1080/14786419.2023.2202398.
   PubMed Web of Science ®Google Scholar
• Seshacharyulu P, Ponnusamy MP, Haridas D, Jain M, Ganti AK, Batra SK. 2012. Targeting the EGFR signaling pathway in cancer therapy. Expert Opin Ther Targets. 16(1):15–31. doi:10.1517/14728222.2011.648617.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fuchs HE, Jemal A. 2022. Cancer statistics, 2022. CA Cancer J Clin. 72(1):7–33. doi:10.3322/caac.21708.
   PubMed Web of Science ®Google Scholar
• Singh TP, Singh OM. 2018. Recent progress in biological activities of indole and indole alkaloids. Mini Rev Med Chem. 18(1):9–25. doi:10.2174/1389557517666170807123201.
   PubMed Web of Science ®Google Scholar
• Suliphuldevara Mathada B, Gunavanthrao Yernale N, Basha JN. 2023. The multi-pharmacological targeted role of indole and its derivatives: a review. ChemistrySelect. 8(1):e202204181. doi:10.1002/slct.202204181.
   Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71(3):209–249. doi:10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Swami P, Rathod S, Choudhari P, Patil D, Patravale A, Nalwar Y, Sankpal S, Hangirgekar S. 2023. Fe3O4@SiO2@TDI@DES: a novel magnetically separable catalyst for the synthesis of oxindoles. J Mol Struct. 1292:136079. doi:10.1016/j.molstruc.2023.136079.
   Web of Science ®Google Scholar
• Taghour MS, Elkady H, Eldehna WM, El-Deeb N, Kenawy AM, Elkaeed EB, Alsfouk BA, Alesawy MS, Husein DZ, Metwaly AM, et al. 2022. Design, synthesis, anti-proliferative evaluation, docking, and MD simulations studies of new thiazolidine-2,4-diones targeting VEGFR-2 and apoptosis pathway. PLoS One. 17(9):e0272362. doi:10.1371/journal.pone.0272362.
   PubMed Web of Science ®Google Scholar
• The Lancet 2023. Global cancer: overcoming the narrative of despondency. The Lancet. 401(10374):319. doi:10.1016/S0140-6736(23)00234-9.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. 2015. Global cancer statistics, 2012. CA Cancer J Clin. 65(2):87–108. doi:10.3322/caac.21262.
   PubMed Web of Science ®Google Scholar
• Tran KB, Lang JJ, Compton K, Xu R, Acheson AR, Henrikson HJ, Kocarnik JM, Penberthy L, Aali A, Abbas Q, et al. 2022. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 400(10352):563–591. doi:10.1016/S0140-6736(22)01438-6.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu H, Hou L, Liao J, Zhang P, Zhang H, Wang G, Sun L. 2023. Two new indole alkaloids from Nauclea officinalis and their evaluation for cytotoxic activities. Nat Prod Res. 1–7. doi:10.1080/14786419.2023.2189707.
   Google Scholar
• Yousef RG, Elkady H, Elkaeed EB, Gobaara IMM, Al-Ghulikah HA, Husein DZ, Ibrahim IM, Metwaly AM, Eissa IH. 2022. (E)-N-(3-(1-(2-(4-(2,2,2-trifluoroacetamido)benzoyl)hydrazono)ethyl)phenyl)nicotinamide: a novel pyridine derivative for inhibiting vascular endothelial growth factor receptor-2: synthesis, computational, and anticancer studies. Molecules. 27(22):7719. doi:10.3390/molecules27227719.
   PubMed Web of Science ®Google Scholar
• Zhang YL, Yuan JQ, Wang KF, Fu XH, Han XR, Threapleton D, Yang ZY, Mao C, Tang JL. 2016. The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis. Oncotarget. 7(48):78985–78993. doi:10.18632/ONCOTARGET.12587.
   PubMedGoogle Scholar